9000 kilometres across some really rough terrain – that’s the challenge facing the rally drivers taking part in the “Dakar Rally” in January. Two weeks of stress and strain. The head of motor racing in charge of the teams is under enormous pressure too, but in his case it’s not confined to that single fortnight. All year long he has to put together a car drawing on a given budget; a car that will pose a genuine threat to the competition. At the same time he must organise and supervise: the safety of the entire team, the fitness of the drivers and co-drivers, the transportation of the equipment, and so on and so forth. Mhoch4 has accompanied Volkswagen’s head of motor racing Kris Nissen and seen the extent of the demands made on him on the eve of the Dakar Rally.
https://amzn.to/2BYlA4s : Quick Constipation Relief: Stop Creating Hemorrhoids with Constipation
If you have hemorrhoids, then most likely you are constipated. Here is what you can do to have a quicker bowel movement. Straining and pushing when you have a bowel movement is going to put pressure in your anal veins causing hemorrhoids.
Interim clinical results from Project IMPACT: Diabetes, announced today by the American Pharmacists Association (APhA) Foundation, show statistically significant decreases in A1C or blood sugar levels, LDL cholesterol, systolic blood pressure and Body Mass Index (BMI), which are all recognized standards of diabetes care. Participating patients in 25 communities who experienced improved outcomes encompass almost every socioeconomic class, insurance status and ethnicity.
To view Multimedia News Release, go to http://www.multivu.com/mnr/62268-american-pharmacists-association-apha-foundation-project-impact-diabetes
Matt's performance on March 2nd, 2012 at the Port Jefferson Middle School Talent Show.The
backing track was bass, rhythm guitar, and drums only. Matt did all the
keyboards (electric piano, strings, sampled guitars, synth leads) and
vocals live.
Over 50 PR agencies and in-house PR departments came together to witness the first PR Pressure conference, which took place on Wednesday, 25 May 2016, at the Dusit Thani, Dubai. The event, organised by Secret PR, marks the first of an annual series of conferences that address the struggles faced by PR professionals in the Middle East. Leading up to the next conference, Secret PR will be taking proactive steps towards providing pragmatic solutions for the issues raised at the event.
One of the highlights from the conference was a series of open discussions surrounding opinions on the media and the PR industry. Inspired by a popular hashtag, #UAEPR, the event offered an open and professional approach to the shortcomings of both industries in order to encourage better practice amongst journalists and PR professionals. These sessions were headed by speakers from PR agencies and media, including Nick Rego, Senior Editor at tbreak.com, Sudeshna Ghosh, a consulting editor and freelance writer, Shereen Shabnam, Consultant Head of PR for octOpus and MTE Studios, and Louay Al-Sammarai, Joint Managing Director and Co-Founder of Active (Digital. Marketing. Communications).
To view the multimedia release go to:
http://www.multivu.com/players/uk/7852351-pr-pressure-conference/
Smith & Nephew plc (LSE: SN, NYSE: SNN), the global medical technology business, announces the FDA clearance of the pocket-sized PICO◊ system, a single use Negative Pressure Wound Therapy (NPWT) system. PICO is cleared for use both in a hospital and homecare setting and expands the use of NPWT from the traditional wound care population to include a wider range of patients undergoing orthopaedic surgery, plastic surgery and general surgical procedures. This FDA clearance follows the recent successful launch of PICO in Europe, Canada, and Australia.
To view Multimedia News Release, go to http://www.multivu.com/mnr/51011-smith-nephew-pico-system-fda-approval-npwt
Close-Up TV News recognizes the NYU Langone Weight Management Program as the country’s premier surgical weight loss facility
The term “morbid obesity” is generally defined as being 100 lbs over the ideal weight or having a Body Mass Index between 35 and 40. Morbid obesity significantly can increase a patient’s risk for diabetes, heart disease and high blood pressure. Unfortunately, for these patients, diet and exercise alone cannot offer a practical solution.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/thinforlife/50245/
At the heart of Ketel One Vodka lies one family’s unwavering passion for crafting the world’s finest spirits. Inspired by over 325 years of distilling expertise, the Nolet family brings old-world pot still craft and modern distilling techniques together in one flawless process. From Joannes to Jacobus to Carolus Sr., creator of Ketel One Vodka, to Carolus Jr. and Bob Nolet today, each of the 11 generations of Nolet family distillers is tasked with upholding a legacy of distilling excellence. Some may consider the Nolets a little obsessive, but those individuals just don’t understand. Everything must be done with meticulous attention to detail, because the family name is riding on every bottle of Ketel One Vodka.
“We take our work very seriously, not ourselves,” said Carl Nolet Jr., 11th Generation Nolet Family Distillery. “The stories we tell are all true and based on family events, beliefs and the pressure of upholding 11 generations of legacy for generations to come.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7975151-ketel-one-vodka
REMBRANDT®, the original at-home teeth whitening brand, enters the power toothbrush market for the first time with the launch of its power Whitening Toothbrush and Whitening Brush Heads, rounding out the brand’s suite of highly effective, scientifically proven teeth whitening solutions. The power toothbrush and 3-pack of replacement brush heads are now available online at Amazon.com and Rembrandt.com with a suggested retail price of $59.99 and $19.99 each, respectively.
REMBRANDT’S unique design features two brushing modes—Whitening and Sensitive—to allow consumers the ability to customize their daily whitening experience.
Based on in vitro laboratory testing, the REMBRANDT® Whitening Toothbrush and Brush Heads demonstrated seven times more plaque removal compared to a manual toothbrush. The rechargeable handle features a two-minute timer and a pressure sensor indicator to alert the user if they’re brushing too hard.
To view the multimedia release go to:
https://www.multivu.com/players/English/8240751-rembrandt-whitening-power-toothbrush/
Nearly six of ten Americans will develop kidney disease in their lifetime, according to a new analysis published in the American Journal of Kidney Diseases. In comparison, lifetime risk of diabetes, heart attack and invasive cancer is approximately four in ten.
As a result of this and previous studies, the National Kidney Foundation is calling on healthcare professionals to screen patients in specific high-risk groups for kidney disease – those age 60 or older and those with high blood pressure or diabetes – by adding a simple urine albumin test for kidney damage to annual physical examinations.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/62772-national-kidney-foundation-study-screening-for-disease
Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, announced today that many retina specialists throughout the U.S. are now using ILUVIEN® (fluocinolone acetonide intravitreal implant) 0.19 mg to treat patients with diabetic macular edema (DME). The first injections of ILUVIEN in the U.S. were captured during a live web event attended by more than 250 eye care professionals. ILUVIEN is the first multiyear eye implant designed to deliver a continuous, submicrogram daily dose of steroid to the retina for 36 months with one injection. ILUVIEN is indicated for the treatment of DME in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure (IOP).
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7496251-iluvien-dme/
